GGrantIndex
← Leaderboards

Rheal A Towner

University Of Oklahoma Hlth Sciences Ctr

$4,873,051
Attributed
$7,072,443
Total exposure
21
Grants
16
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.2M · FY200519
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19

Funding mix

By agency

NIH$7,072,443 · 21

By mechanism

R01$2,932,523 · 1
P20$2,831,633 · 16
S10$600,000 · 1
R21$401,392 · 1
R03$306,895 · 2

Top collaborators

Most similar at University Of Oklahoma Hlth Sciences Ctr

Same institution · by research overlap

Others in their field

Top investigators on “Magnetic Resonance Imaging

Research focus

Magnetic Resonance ImagingImageMolecularContrast MediaRattusBaseIn VivoMolecular TargetMetabolicTissuesFutureMalignant NeoplasmsFundingUnited States National Institutes Of HealthAnimalsInstitutionResourcesOklahomaSourceTumorGrantBrainMonitorRodent

Grant awards (29)

Causes, consequences, imaging and mitigation of sepsis-induced encephalopathy$581,379
R01 · FY2019 · NS
Causes, consequences, imaging and mitigation of sepsis-induced encephalopathy$593,428
R01 · FY2018 · NS
Pre-Clinical 7T MRI for Oklahoma$600,000
S10 · FY2017 · OD · contact PI
Causes, consequences, imaging and mitigation of sepsis-induced encephalopathy$593,428
R01 · FY2017 · NS
Causes, consequences, imaging and mitigation of sepsis-induced encephalopathy$576,124
R01 · FY2016 · NS
Causes, consequences, imaging and mitigation of sepsis-induced encephalopathy$588,164
R01 · FY2015 · NS
SMALL ANIMAL IMAGING$160,376
P20 · FY2011 · RR · contact PI
BIO2010$102,786
P20 · FY2011 · RR · contact PI
Therapeutic Evaluation of Magnetic Nanoprobes Specific for Malignant Tumor Marker$217,163
R21 · FY2010 · CA · contact PI
COBRE: OK MED RES FOUND: CORE IV: MRI IMAGING IN VIVO$175,739
P20 · FY2010 · RR · contact PI
BIO2010$101,035
P20 · FY2010 · RR · contact PI
Therapeutic Evaluation of Magnetic Nanoprobes Specific for Malignant Tumor Marker$184,229
R21 · FY2009 · CA · contact PI
MRI CORE$143,618
P20 · FY2009 · RR · contact PI
Chemoprevention of Gliomas using Nitrones with Anti-c-Met Activity$79,500
R03 · FY2009 · CA · contact PI
MRI CORE$130,322
P20 · FY2008 · RR · contact PI
Chemoprevention of Gliomas using Nitrones with Anti-c-Met Activity$77,500
R03 · FY2008 · CA · contact PI
COBRE: OK MED RES FOUND: CORE IV: MRI IMAGING IN VIVO$135,894
P20 · FY2007 · RR · contact PI
MRI CORE$97,647
P20 · FY2007 · RR · contact PI
Molecular-Specific Detection of Tumors: MRI Investigations$73,845
R03 · FY2007 · CA · contact PI
ANTIOXIDANT INHIBITION OF GLIOMAS: MRI/MRS EVALUATION$50,331
P20 · FY2007 · RR · contact PI
COBRE: OK MED RES FOUND: CORE IV: MRI IMAGING IN VIVO$140,714
P20 · FY2006 · RR · contact PI
MRI CORE$139,237
P20 · FY2006 · RR · contact PI
ANTIOXIDANT INHIBITION OF GLIOMAS: MRI/MRS EVALUATION$104,393
P20 · FY2006 · RR · contact PI
Molecular-Specific Detection of Tumors: MRI Investigations$76,050
R03 · FY2006 · CA · contact PI
MRI CORE$140,988
P20 · FY2005 · RR
COBRE: OK MED RES FOUND: CORE IV: MRI IMAGING IN VIVO$139,158
P20 · FY2005 · RR
ANTIOXIDANT INHIBITION OF GLIOMAS: MRI/MRS EVALUATION$105,741
P20 · FY2005 · RR
CORE--FMRI NEUROIMAGING$680,936
P20 · FY2004 · RR
CORE--MRI IMAGING IN VIVO$282,718
P20 · FY2004 · RR